Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rebound occurs at a similar rate for those receiving and not receiving oral antiviral treatment and for those receiving nirmatrelvir/ritonavir or placebo, according ...
Dec 22, 2023
0
0
B cell deficiency is a common condition that can result either from immunosuppressant drugs used to treat autoimmune disease or certain cancers—such as rituximab (RTX)—or from natural immune deficiency. These patients ...
Dec 18, 2023
0
44
A new study identifies alterations in the transcriptomic signatures in human olfactory mucosal cells of individuals with Alzheimer's disease following SARS-CoV-2 infection, potentially contributing to exacerbated COVID-19 ...
Dec 15, 2023
0
16
Lung airway cells of people with alcohol use disorder developed "enhanced inflammation" three days after being infected with SARS-CoV-2, the virus that causes COVID-19, according to a new study from Emory University School ...
Dec 12, 2023
0
0
One to two weeks after contracting COVID, the SARS-CoV-2 virus generally becomes undetectable in the upper respiratory tract. But does that mean that it is no longer present in the body? To find out, a team from the Institut ...
Dec 8, 2023
1
85
Although SARS-CoV-2 is no longer a stranger to the immune system, new virus variants still pose a challenge. The working group led by Professor Dr. Florian Klein, Director of the Institute of Virology at the University Hospital ...
Dec 7, 2023
0
22
A new study published in the American Journal of Infection Control (AJIC), based on a survey of health care professionals conducted during the height of the COVID-19 pandemic, suggests that new efforts may be needed to strengthen ...
Dec 7, 2023
0
1
Researchers have discovered a novel mechanism whereby the SARS-CoV-2 virus, which causes COVID-19, can vary its mode of infection in human cells. In work published in the journal eLife, a team from the University of Minnesota ...
Dec 5, 2023
0
92
Coronaviruses are a global public health risk, with three highly infectious species, including SARS-CoV-2, emerging in the last 20 years. New research by the University of Bristol has shown how an HIV drug could stop many ...
Dec 5, 2023
0
59
University of Queensland-led research shows being overweight can impair the body's antibody response to SARS-CoV-2 infection but not to the protection offered by vaccination.
Dec 3, 2023
0
23
